Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (350)	1/17/1999 8:27:00 PM
From: geewiz	Respond to of 534

Hi Mark, All, Thanks for thoughts on the PowerJect company. I have visited the PowerJect web site several times; powderject.com I thought the gold particle injection was a joke; when the Japanese were doing well several years ago they used to sprinkle their drinks with gold dust! However on looking closely the company is doing a lot of work in the particle formulation techniques; from Powerject press release; BPD has developed a particle process based upon the technique of precipitation of particles of a pharmaceutical compound from solution by mixing the solution with a super-critical fluid - such as liquid carbon dioxide -in which the pharmaceutical compound is not soluble. This single process precipitates the pharmaceutical compound in the form of particles with controlled size, density and crystallinity. The technique may also be used to co-precipitate novel combinations of compounds. The company has some scientific maxi. A subsidiary is located in Wisconsin and recently completed phase one trials; MADISON FIRM REPORTS DNA VACCINE SUCCESS MILWAUKEE JOURNAL DECEMBER 12/1998 For private use; Using a "gene gun" to fire virus genes into patients' skin, a Madison company says it has immunized 11 people against the hepatitis B virus in recently completed clinical trials........ In the test, harmless pieces of viral DNA were blasted into patients using a "gene gun," which fires a shotgun-like blast of microscopic gold dust on shich the DNA rides...... This is the first time a so-called DNA vaccine has ever produced "protective immunity" to a disease, PowderJect Vaccines Inc. President Schaefer Price said in an interview...... The successful clinical trial triggers a $1 million payment to PowderJect by Glaxo Wellcome Inc. under a collaborative agreement... ........................... It's significant that the phase one clinical trials are being conducted in the United States. The funding came from Glaxo, a British company, yet the trials were done stateside by a subsidiary of PowerJect. From PowerJet press release; PowderJect Vaccines Inc., located in Madison WI, is focused on the application of the PowderJect technology to the administration of genetic and conventional vaccines. The company is developing products for the prevention and treatment of a broad range of infectious diseases and cancer. Additional applications of the PowderJect Vaccines technology include auto-immune diseases, allergies and other immunopathologies. PowderJect Pharmaceuticals Plc, based in Oxford England, Fremont California and Madison Wisconsin USA, was established in 1993 to exploit research at Oxford University in the field of drug and vaccine delivery. PowderJect has become the world leader in the field of particle mediated injection of medicines, developing novel products for leading pharmaceutical companies based upon the use of its proprietary powder injection systems. PowderJect Vaccines Inc. is a wholly owned subsidiary of PowderJect Pharmaceuticals plc. More information can be found on the company's web site at powderject.com <i/> There are a number of other interesting press releases at the powerJect web-site. Thanks for your thoughts. later, art